Menu
ncarol.com
  • Home
  • Music
  • Asheville Music
  • Books
  • Manufacturing
  • Health
  • Technology
  • Financial
  • Entertainment
ncarol.com

DG Meditech Opens Doors to North American Operations With Appointment of New Chief for Americas
ncarol.com/10139625

Trending...
  • USA Air Management Marks 30 Years of Air Duct Cleaning in NJ Urges Homeowners to Schedule Dryer Vent Cleaning Before Heating Season
  • Growth Story Expands: $54.6M Contract, $30M Revenue Run Rate, 800+ Customers, 50+ Patents & New AI Cybersecurity Products for Cycurion, Inc $CYCU
  • Sky Quarry Restarts Nevada's Only Crude Oil Refinery — A Major New Chapter Begins in This Highly Lucrative sector for N A S D A Q: SKYQ
DGMeditech
TRAVERSE CITY, Mich. & TORONTO - ncarol.com -- The DG Meditech today announced the appointment of Davis Gravelsins as Chief Executive Officer, US Operations. Previously working as Senior Liaison Digital Transition - Healthcare on projects in the Baltic and in the E.U., Mr. Gravelsins will now be heading up DG Meditech's service expansion into North and South American geographies.

Founded in Daugavpils, Latvia in 1989 as Derzins Glochsteinbacher Medicīnas Programmatūras Risinājumu Korporācija, (DGMPR Korp.) the company rebranded in 2020 as DG Meditech to expand into markets outside of Europe, where is known for its large service offering of digital transformation services, working with government and state-run corporate clientele in acute and long-term care, as well as in medical, therapeutic, homecare and behavioral areas.

Eying new international opportunities, the company opened offices in Traverse City, Michigan and Toronto, Canada prior to the onset of Covid-19, and has since built agile consulting teams in each city. These teams of consist of consultants, analysts, compliance experts and finance personnel who are working under Mr. Gravelsins to finance and manage new North American investment opportunities for DG Meditech's European clients.

More on ncarol.com
  • NYC Banners Delivers High-Stakes UN General Assembly Backdrop for the US Department of State Event
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Tampa Bay Reporter Launches with a Mission to Deliver Local News with National Reach
  • "JACKIE the STRIPPER," Starring Charlotte Kirk and The PUSSYCAT DOLLS' Kimberly Wyatt, Now Streaming on PRIME
  • Migguel Anggelo Celebrates the Immigrant Experience, Latino Identity, and the Power of Iconic Latin Rhythms During Hispanic Heritage Month

Operating as DGMPR Korp. and now as DG Meditech, the company has provided digital transformation services including finance, purchasing and software solution optimization expertise for dozens of clients for over three decades, deploying some of the first EHR and IMS solutions in European state-run and private healthcare.

The company's clients include ACOs, hospitals, home care groups, Skilled Nursing Facilities, senior living organizations, along with many long-term care facilities and their government funding organizations.

"I am very excited to be heading up our expansion from Europe to the Americas. Many of our clients are well down the transformation path, and are now actively pursuing management and purchasing opportunities in Canada, the USA, Mexico, Brazil and Argentina. We are pleased to be part of this global drive to expand operations while digitally transforming client's portfolios." Said Mr. Gravelsins.

-        30  –

For more information, please contact us:

Toronto, Canada Office: Mr. D. Gravelsins

davis.gravelsins@dgmeditech.com

Travers City Office: Mr. J. Anson

janson@dgmeditech.com – 705-943-8225

Contact
Davis Gravelsins
***@dgmeditech.com


Source: DGMeditech

Show All News | Disclaimer | Report Violation

0 Comments
1000 characters max.

Latest on ncarol.com
  • [New Book] "Historic Maps of Charlotte" Available Now!
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • HuskyTail Digital Puts AI to Work Behind the Scenes to Cut Client Turnaround Time
  • AI, Real-World Data "RWD" and U.S. Expansion Put Predictive Healthcare in Focus for POMDOCTOR Ltd. (N A S D A Q: POM)
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • 2026 Triangle Parade of Homes Features Over 300 Homes
  • "Next Friday" Star Mike Epps Hits Cherokee as KayeDinero Drops "Cherokee"
  • P-Wave Classics to publish Thomas Holcroft's The Adventures of Hugh Trevor in three volumes, beginning 19 January
  • Ad Leverage Sponsors ServiceTitan Pantheon 2026, Supporting Education and Growth in the Home Services Industry
  • Travel Season Turns to the Smokies as KayeDinero Turns Cherokee Into a Song
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Badanamu Partners With Moonbug Entertainment In Landmark Distribution Deal
  • Cabinet Revolution Expands Affordable Cabinet Options for High Country Homes
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Oral statement on the situation of Chairman Lee Man-hee in pretrial detention in the Republic of Korea
  • Shuttle Buddy Announces Amazon Partnership to Launch Workforce Express in North Carolina
  • Inlow Upholstery Helps Cleveland County Homeowners Refresh Furniture with Custom Upholstery
  • Birthstones Are Having a 2026 Moment. KayeDinero's "Aquamarine" Began With Her Grandmother
  • Names Are Not Important Asks What Remains When Identity Is Stripped of Labels
  • Most Utah Deaths Never Reach the Medical Examiner. Postmortem Pathology Offers Salt Lake City a Private Autopsy Option
_catLbl0 _catLbl1

Popular on ncarol.com

  • Mito Health Passes One Million Lab Tests, Expands to Seven Categories of Preventive Health Testing - 176
  • Free JavaScript Charting Library ProEssentialsJS Permits Commercial Use. Highcharts, SciChart and LightningChart Free Tiers Do Not - 159
  • Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 149
  • Patented Foodservice Products Company with Strong Gross Margins and Substantial Two-Year Revenue Growth Hits Market for $1.6 Million - 133
  • MommyAndMe.club Expands Parent-Child Class Directory to All 50 States and Washington, D.C - 109
  • Warrant Activity, AVERSA™ Progress and a Potentially Transformative Fall Take Center Stage: Nutriband Inc. (N A S D A Q: NTRB) - 108
  • Church Tradition Takes an Unexpected Turn at the Ford Community & Performing Arts Center - 108
  • Badanamu and Friends Live Brings Hit Animated Series to Stages Across the United States - 102
  • ChargeOn Announces Conversational Payment Management Solution - 102
  • Santa Your Way Announces Official 2026 Q4 Holiday Tour: Booking Open For Santa, The 5-star Grinch, And Dual Character Experiences Nationwide

Similar on ncarol.com

  • Harvard Educated Board Certified Endodontist Joins Pearlfection Dentistry
  • OneVizion Appoints Energy Infrastructure Executive Walt Farrell to Board of Directors
  • Infinity Infusion Solutions Launches "Women Leading Infusion Care" Campaign for National Women in Business Month
  • $11.18 Million DARPA Award Ignites a Major New Catalyst as FDA, Robotic TMS and Commercialization Milestones Converge for NRx Pharmaceuticals, Inc
  • DBF Viewer 2000 v9.32 Adds New Control for Data Export
  • Nutriband (N A S D A Q: NTRB): Fighting Back Against the Fentanyl Crisis With a New Approach to Safer Transdermal Medicines
  • Massage Revolution Expands to Santa Monica With New Wilshire Boulevard Location
  • Dr. Jay Johannigman Returns to Cincinnati Following 46 Years of Military Service
  • Nutriband Inc. (N A S D A Q: NTRB) Breaks Into Uncharted Territory: 52-Week High Eclipsed as Shares Surge 22% —AVERSA™ Puts Investors on High Alert
  • Transformational $104 Million Musculoskeletal Healthcare Opportunity as Expansion Strategy Accelerates for Cardiff Lexington Corp (Stock Symbol: CDIX)
Copyright © 2026 ncarol.com | Contact Us | Privacy Policy | Terms of Service | Contribute